Latest Shareholder Approval News

Aruma Resources has significantly expanded its Tillex Copper-Silver Project in Ontario by acquiring 94 new claims, extending the copper trend to 2.4 kilometres and raising $3.5 million to accelerate exploration.

PTR Minerals has bolstered its leadership team by appointing mineral sands veteran Colin Bwye as Non-executive Director and elevating Rob Sennitt to Managing Director, aligning with its push to develop the high-grade Rosewood Titanium Project in South Australia.

RLF AgTech is set to raise $3.9 million through a share placement and convertible notes, aiming to capitalise on recent operational restructuring and accelerate commercial execution in FY27.

Tartana Minerals has secured a $2.3 million placement from Xingye Gold, which now holds just under 10% of the company but declines further rights or involvement.

Arrow Minerals has uncovered seven decades-old drill cores at the GSWA library, validating historical mineralisation at its Yarraloola Copper Project in WA's Pilbara and setting the stage for a targeted 2026 drilling campaign.

Minbos Resources has expanded its capital raise to A$6 million, reflecting robust investor appetite to support the Cabinda Phosphate Project’s critical development phase.

Koonenberry Gold has completed its acquisition of the Gundagai Gold-Copper Project, adding 485km2 to its Lachlan Fold Belt portfolio and unlocking multiple high-grade targets for near-term drilling.

Bio-Gene Technology has raised approximately A$3.275 million through its second tranche placement and share purchase plan underwriting, issuing over 51 million new shares and 69 million options to investors.

MRG Metals has secured $800,000 through a placement and board commitment to accelerate development at its ultra high-grade Garies Rare Earth Project in South Africa and advance exploration in Mozambique.

BetMakers Technology Group has inked a binding deal for Tabcorp to acquire it at a 45.5% premium, valuing the wagering tech firm at about $283 million. Shareholders can opt for cash or a mix of cash and Tabcorp shares, with completion aimed for Q3 FY27.

Tabcorp Holdings has agreed to acquire BetMakers Technology Group for approximately $267 million, aiming to accelerate its wagering technology upgrade and expand its global B2B footprint. The deal targets $30 million in cost synergies by Year 2 and expects double-digit EPS accretion by Year 3.

Percheron Therapeutics announces Dr Michael Baker as incoming CEO, replacing Dr James Garner who steps down after three years. Baker’s appointment aligns executive incentives with shareholder value as the company prepares for a pivotal HMBD-002 clinical trial.